Researchers from Oxford BioMedica company developed a new tool for injection into the brain, which contains three genes that play a key role in developing Dopamine . When injected into the brain, carried out under anesthesia, the drug restores stocks Dopamine in the body and thereby facilitates the health status of patients with Parkinson's disease.
As is known, Parkinson's disease It causes the death of brain cells that produce Dopamine . This substance is necessary for our body to coordinate movements, which is why people with Parkinson's disease there is a tremor of the limbs and other muscle problems.
In a clinical study of a new drug has already passed nine patients. All of them reported a significant improvement in well-being, including reducing the degree of shaking limbs and tremors by 43%. One patient health status improved by 61%.
No serious side effects have not yet been observed, as was announced at a meeting of the American Association of cell and gene therapy. In the near future will be held a new trial drug, but before its release in the broad practice will take at least six years.
In Russia, according to various estimates, there are between 117 000 to 338 000 patients with Parkinson's disease at different stages. The main drug against the disease are drugs levodopa. They increase the production of dopamine, but sometimes cause muscle problems.
Industry News
Go back to the main page
Немає коментарів:
Дописати коментар